Tempus is a Chicago based technology company founder in the year 2015. It is building the world’s most extensive library of molecular, clinical data and an operating system to make that data most useful and accessible. We equip our physicians with skills to deliver personalized cancer care for patients through the interactive analytical and available machine learning platform.
Unicorn Company offers genomic sequencing services, therapeutic and analyzed molecular data to empower our physicians in making real-time and data-driven decisions. Physicians receive better tools to learn as the organization gathers more data purposely to benefit cancer patients.
Tempus on 20th March 2018 announces through Chicago news magazine announced that it had raised $80 million more funds in financing development projects. The round comprised of New Enterprise Associates, the existing investors, and new investors Kinship Trust Company. Rowe T. Price Associates, Inc. advised these funds. The foundered firm has raised funds amounting to $210 million in all funding to date. Additional funds are set to scale and further growth of the Tempus’ clinical and molecular analytic platform.
Tempus experienced challenging factors with the health care system before attaining its strength where useful data and real-world evidence got wasted. Eric Lefkofsky, the co-founder and the Chief Executive Officer of Tempus stated that the company is in an excellent position to usher in the era of precision medicine to help cancer patients only when given the scale and breadth of current data set.
The organization finds it hard to scale efforts of cancer treatment without centralizing large amount of therapeutic, phenotypic and molecular data because of isolated personalized medicine. Tempus has strived to solve this issue by building a stable ecosystem to collect, sort, analyze, and apply data solutions to healthcare and oncology through a suite of products that control clinical decision support and cutting-edge research.
Apart from working with independent oncologists, The company has also partnered with several cancer research hospitals like the University of Michigan, Mayo Clinic, University of Chicago, Northwestern University, the Cleveland Clinic, Duke University School of Medicine and Knight Cancer Institute. Tempus Unicorn currently works with nearly half of Academic Medical Research Centers in the United States.
To Learn More Click Here